GE Healthcare and BAC collaborate to launch new bioprocess affinity resin

21-Mar-2012 - United Kingdom

GE Healthcare and BAC BV announced that, following a successful collaboration between the two companies, GE Healthcare Life Sciences has added a new affinity resin to its portfolio of technologies for the purification of antibody-based fragments. GE Healthcare’s new resin, LambdaFabSelect, is a designed tool for the GMP-regulated purification of antibodies and antibody fragments that contain a lambda light chain. Antibody fragments are receiving increased attention as potential future biopharmaceuticals because, compared with monoclonal antibodies, they have a number of advantages such as improved tissue penetration and the ability to bind to targets inaccessible to conventional antigen-binding sites.

Other news from the department research and development

These products might interest you

Cytiva Protein Select New

Cytiva Protein Select by Cytiva

Fast & Efficient Protein Purification with Cytiva’s Self-Cleaving Resin

Boost your lab's efficiency by simplifying purification with a tag-free solution

chromatography resins
TOYOPEARL® AF-rProtein L-650F

TOYOPEARL® AF-rProtein L-650F by Tosoh

High-Performance Protein L Resin for Effective Antibody Purification

chromatography resins
Fibro

Fibro by Cytiva

Fibro chromatography

Rapid cycling single-use chromatography

chromatography accessories
MabSelect

MabSelect by Cytiva

Optimise your antibody purification

High-performance resins for pure results in biotechnology

chromatography resins
Loading...

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous